Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Todos Medical Ltd TOMDF

Todos Medical Ltd is a Israel-based clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer. The Companys Total Biochemical Infrared Analysis (TBIA) platform, represents a method for cancer screening of solid tumors using peripheral blood spectroscopy analysis. The process involves observing the immune system’s response to tumor presence. TBIA analyzes the entire biochemical signatures spectrum including proteins, lipids, nucleic acids and carbohydrates of effected immune cells from peripheral blood, using infrared spectroscopy.


GREY:TOMDF - Post by User

Post by Red~Oneon Aug 22, 2022 10:55am
74 Views
Post# 34911302

Todos launches monkeypox PCR test in US

Todos launches monkeypox PCR test in USTodos launches monkeypox PCR test in US

 

  • Todos Medical ( OTCQB:TOMDF said its laboratory Provista Diagnostics completed CLIA validation and commercially launched lesion and saliva-based monkeypox PCR testing in the U.S.
  • Provista will collect saliva samples matched with lesion swabs from confirmed MonkeyPox cases before launching a standalone laboratory-developed test (LDT) targeted at identifying monkeypox in the pre-symptomatic stage, the company said in an Aug. 22 press release.
  • Todos noted that Provista currently has PCR automation capacity to run 25K PCR tests per day with ongoing efforts to increase the capacity to 50K tests per day.
  • The Israeli company added that it is also preparing validation plans for an IgM/IgG blood-based monkeypox LDT to confirm recent infection as part of a planned MonkeyPox Panel.
  •  

<< Previous
Bullboard Posts
Next >>